Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: Francis desouza | History Defined

Scale AI taps former Google Cloud executive as CEO

Scale AI appointed Francis DeSouza as chief executive officer, effective August 10. DeSouza brings over thirty years of enterprise technology experience to the AI company. He previously led Google Cloud's security products and served as Illumina's CEO. Scale AI recently added BP and Mayo Clinic as new enterprise customers. The…

The Economic Times

'An AI-led defense strategy that's overseen by humans': Google is introducing more agents to its 'full AI stack' to allow AI security at 'infinite scale'

'An AI-led defense strategy that's overseen by humans': Google is introducing more agents to its 'full AI stack' to allow AI security at 'infinite scale'

Three new agents introduced at Google Cloud Next, which are soon to be released.

Alphabet: The AI Powerhouse Driving Markets Into 2026

Alphabet: The AI Powerhouse Driving Markets Into 2026

The launch of Gemini Enterprise marks Google’s push to embed AI across enterprise workflows, integrating its full-stack infrastructure from Cloud to Workspace.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Google exec says every company needs these 2 types of AI talent

Tech companies want people who excel at building AI systems, and leaders who are adept at utilizing them.

Inside Illumina’s bruising proxy battle with billionaire activist investor Carl Icahn

Illumina’s contentious acquisition of cancer test maker Grail brought billionaire Carl Icahn to the company’s doorstep.

Illumina’s Sudden CEO Exit Is Just One of Many Problems Facing DNA Company

The sudden resignation of Francis deSouza raises questions about the firm’s future after its proxy fight with Carl Icahn.

What CEOs think about the increasing focus on employee wellness

"People understanding that we embrace their uniqueness actually drives better connection to the company."

inkl

Read news from The Economist, FT, and more,
with one subscription

Illumina Reports 41% Dip In Q1 Profits Despite 12% Jump in Sales, Reaffirms FY22 Guidance

Illumina Reports 41% Dip In Q1 Profits Despite 12% Jump in Sales, Reaffirms FY22 Guidance

Illumina Inc's (NASDAQ:ILMN) Q1 FY22 revenues rose 12% Y/Y to $1.22 billion, in line with estimates. Nearly all revenues came from the core Illumina business; GRAIL, Illumina's cancer liquid biopsy subsidiary, recorded revenues of $10 million. Product revenue for the quarter totaled $1.07 billion, up 12%, and Service and other revenue amounted to…

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

British Petroleum

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

418,072 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play